[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Wiley-Blackwell to Launch Archives of Drug Information

Media Contact:
Ginny Foley

For Immediate Release

Wiley-Blackwell to Launch Archives of Drug Information
Journal to Increase Public Access to Latest Research from 
Pharmaceutical Industry

Hoboken, New Jersey-March 5, 2007 - Wiley-Blackwell announced the 
launch of Archives of Drug Information (ADI), a new open access, 
freely available peer-reviewed journal, dedicated to publishing 
the results of drug studies. This journal will help to address 
requests for transparency voiced by societies, health care 
practioners, patients, media, and the government to disclose 
clinical trial information.

ADI is unique because it will publish not only results of 
clinical trials and drug studies, but also articles on 
inconclusive and/or negative clinical trials, early drug 
development, routine drug-drug interaction, pharmacokinetic 
studies, and other low-profile areas that are traditionally 
overlooked. The first articles will be published online April 

"ADI will provide an unbiased, scientific home for high-quality 
information that should be in the public domain but currently 
resides on file somewhere," says Dr. C. Michael Stein, Editor of 
Archives of Drug Information. "It will also help prevent 
scientists in drug development from repeating mistakes or 
following the same blind alleys others have explored because that 
information has never been published." ADI will publish a broad 
range of research, including cellular, animal, and human studies.

While some government and pharmaceutical companies provide 
repositories to register clinical data and public databases to 
post clinical trial results, sources for independent publication 
are very limited.  As a result, the findings of many drug 
development studies and clinical trials remain unpublished. 
Archives of Drug Information will bridge this gap by publishing 
data from clinical trials thereby disclosing results promptly to 
the researcher, clinician and the public. With ADI, it will be 
possible for everyone to freely search every published article to 
locate specific trials, methods, and experimental results.

"This new journal is an exciting opportunity for Wiley-Blackwell 
to help the medical and pharmaceutical communities advance the 
innovative work of drug discovery and to help patients and their 
families understand the risks and benefits of prescription 
medicines," says Sue Corbett, Vice President and Managing 
Director, Medicine, Wiley-Blackwell. "Archives of Drug 
Information will become a resource for scientists, physicians, 
patients, and students worldwide by providing free access to 
information that has previously been inaccessible."

For more information on submitting papers to ADI, please contact 

About Wiley-Blackwell
Wiley-Blackwell was formed in February 2007 as a result of the 
merger between Blackwell Publishing Ltd. and John Wiley & Sons, 
Inc.'s Scientific, Technical, and Medical business. Together, the 
companies have created a global publishing business with deep 
strength in every major academic and professional field. 
Wiley-Blackwell publishes approximately 1,250 scholarly 
peer-reviewed journals and an extensive collection of books with 
global appeal. For more information on Wiley-Blackwell, please 
visit www.blackwellpublishing.com or 

About Wiley
Founded in 1807, John Wiley & Sons, Inc. provides must-have 
content and services to customers worldwide. Wiley's core 
businesses include scientific, technical and medical journals, 
encyclopedias, books and online products and services; 
professional and consumer books and subscription services; and 
educational materials for undergraduate and graduate students and 
lifelong learners. Wiley has publishing, marketing and 
distribution centers in the U.S., Canada, Europe, Asia and 
Australia. Wiley's European operations are based in Chichester, 
U.K. The Company is listed on the New York Stock Exchange under 
the symbols JWa and JWb. Wiley's Internet site can be accessed at